Cite

HARVARD Citation

    He, L. et al. (n.d.). The mechanism of anti-tumor immunity induced by varlilumab, a CD27 agonist mAb, is model dependent. Journal for immunotherapy of cancer. p. . [Online]. 
  
Back to record